These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15735739)

  • 1. TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage.
    Dubrovska A; Kanamoto T; Lomnytska M; Heldin CH; Volodko N; Souchelnytskyi S
    Oncogene; 2005 Mar; 24(14):2289-97. PubMed ID: 15735739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA2 and Smad3 synergize in regulation of gene transcription.
    Preobrazhenska O; Yakymovych M; Kanamoto T; Yakymovych I; Stoika R; Heldin CH; Souchelnytskyi S
    Oncogene; 2002 Aug; 21(36):5660-4. PubMed ID: 12165866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
    Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
    Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway.
    Pavio N; Battaglia S; Boucreux D; Arnulf B; Sobesky R; Hermine O; Brechot C
    Oncogene; 2005 Sep; 24(40):6119-32. PubMed ID: 16007207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity.
    Grimsby S; Jaensson H; Dubrovska A; Lomnytska M; Hellman U; Souchelnytskyi S
    FEBS Lett; 2004 Nov; 577(1-2):93-100. PubMed ID: 15527767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional proteomics of transforming growth factor-beta1-stimulated Mv1Lu epithelial cells: Rad51 as a target of TGFbeta1-dependent regulation of DNA repair.
    Kanamoto T; Hellman U; Heldin CH; Souchelnytskyi S
    EMBO J; 2002 Mar; 21(5):1219-30. PubMed ID: 11867550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells.
    Edmiston JS; Yeudall WA; Chung TD; Lebman DA
    Cancer Res; 2005 Jun; 65(11):4782-8. PubMed ID: 15930298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
    Imoto S; Sugiyama K; Sekine Y; Matsuda T
    FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
    Cousineau I; Abaji C; Belmaaza A
    Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of transforming growth factor-beta1/Smad3 signaling in bronchiolitis obliterans following lung transplantation].
    Liu HX; Li Y; Zhao CH; Liu Y; Zhang QG; Cong W; Lan XG; Xu S; Han LB; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2069-73. PubMed ID: 17925182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
    Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
    Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
    Koehn H; Magan N; Isaacs RJ; Stowell KM
    Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the BRCA1 tumor suppressor in DNA double-strand break repair.
    Zhang J; Powell SN
    Mol Cancer Res; 2005 Oct; 3(10):531-9. PubMed ID: 16254187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoproteome profiling of transforming growth factor-beta (TGFbeta) signaling: nonglycosylated cell death-inducing DFF-like effector A inhibits TGFbeta1-dependent apoptosis.
    Iwahana H; Yakymovych I; Dubrovska A; Hellman U; Souchelnytskyi S
    Proteomics; 2006 Dec; 6(23):6168-80. PubMed ID: 17080483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines.
    Crowe DL; Lee MK
    Breast Cancer Res; 2006; 8(1):R1. PubMed ID: 16417649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors.
    Lacerte A; Korah J; Roy M; Yang XJ; Lemay S; Lebrun JJ
    Cell Signal; 2008 Jan; 20(1):50-9. PubMed ID: 17881189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4.
    Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A
    Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
    Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
    Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.